High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Learn how a yield-focused dividend ETF can fit into a retirement plan, delivering income while maintaining simplicity and liquidity.
19,425 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Rivian vs. Lucid pits two high-profile EV startups against each other. This guide breaks down business models, capita...
Megapot has secured $5 million in a Dragonfly-led round to scale a crypto-powered global lottery. The platform now se...
Vornado Realty Trust CEO Steven Roth used a quarterly earnings call to harshly rebuke New York City's tax agenda, cal...
Lam Research shares jump on stronger AI-related demand for semiconductor equipment. With foundries expanding capacity...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...
Plaid’s CFO highlights a surge in internal AI experiments as teams share weekend builds. The push comes as Plaid expa...
NVIDIA breached a $5.5 trillion market cap, marking a historic leap for a chipmaker tied to AI. The move highlights t...
A new wave of legal challenges has hit kardashian’s skims with lawsuit, shaking up the brand’s polished image. This a...
As lawmakers push hundreds of AI bills, a lack of universal testing leaves companies and investors facing a maze of r...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...